|
Anxiety and Vagal Control of the Heart in Coronary Disease Clinical Trials Info presented on Clinical Trials Search is not intended to be a substitute for certified medical advice, visits or professional assistance using a real physician. We are not physicians. Always consult your dr. about Anxiety and Vagal Control of the Heart in Coronary Disease conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Anxiety and Vagal Control of the Heart in Coronary Disease Clinical research trials and Anxiety and Vagal Control of the Heart in Coronary Disease health trials happen in many of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new drugs. The function of the studies / projects is to resolve particular human medical questions. Clinical trials are a popular manner for mDs, government agencies, and private sector corporations to discover remedies for all varieties of circumstances, like Anxiety and Vagal Control of the Heart in Coronary Disease. Anxiety and Vagal Control of the Heart in Coronary Disease Clinical Trials and other clinical trials allow volunteers to obtain healthcare treatment options before they are available to the masses. Some times the participants undergo professional assistance for free of charge, and occasionally they are paid for their time. Sometimes there is a cost for a Anxiety and Vagal Control of the Heart in Coronary Disease clinical trial. Human subjects often get the best healthcare available for their Anxiety and Vagal Control of the Heart in Coronary Disease condition. Dangers are a reality, however, and may include additional or frequent mD visits, healthcare dangers (potentially life-jeopardising), and/or the treatment being ineffectual. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > Anxiety and Vagal Control of the Heart in Coronary Disease  Anxiety and Vagal Control of the Heart in Coronary Disease
Anxiety and Vagal Control of the Heart in Coronary Disease
For Condition: Depression,Heart Diseases,Arrhythmia,Coronary Disease,Cardiovascular Diseases,Death, Sudden, Cardiac
Status: No longer recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To examine the role of reduced vagal control of heart rate in the increased risk of cardiac mortality associated with anxiety in a population with established coronary artery disease (CAD). A second objective is to determine whether the effects of anxiety are independent of the effects of depression.
Details: BACKGROUND: Coronary heart disease continues to be the leading cause of death in the United States, despite risk factor reduction and technological advances in treatment options. Prospective studies implicate chronic anxiety as an independent risk factor for fatal coronary heart disease. In particular, anxiety increases the risk of sudden cardiac death substantially. DESIGN NARRATIVE: Nine hundred and fifty CAD patients were recruited for this study from patients hospitalized for elective cardiac catheterization. Anxiety is measured by the Hospital Anxiety Scale, the Spielberger Trait Anxiety Inventory, and the Crown-Crisp Phobic Anxiety Scale. Symptoms of depression are measured by the Montgomery-Asberg Depression Rating Scale, the Hospital Depression Scale, and the Beck Depression Inventory. Vagal control of heart rate is determined using power spectral analysis to measure two indices of vagal control: baroreceptor-mediated vagal reflex cardiac control, and respiratory sinus arrhythmia. Patients are followed at 6 months, l year, 2 years, and 3 years postcatheterization, and cardiac mortality data are obtained, including non-sudden and sudden cardiac death. The data generated by this study are used to examine the involvement of impaired vagal cardiac control in the risk of fatal coronary heart disease and sudden cardiac death associated with anxiety. Specifically, the proposed study examines: (1) the relationship between anxiety and cardiac mortality; (2) the relationship between anxiety and vagal control; (3) the role played by reduced vagal control in mediating anxiety-related risk; and (4) the relationship between depression, vagal control and cardiac risk. Findings of a relationship between anxiety, reduced vagal control and sudden cardiac death would suggest the potential importance of early intervention in cardiac patients with anxiety disorders and would underscore the benefit of aggressive monitoring of arrhythmias in this population, which may ultimately translate to reduced mortality rates.
Eligibility:
Study Type: Observational, Natural History, Longitudinal, Defined Population
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Overall Study Official:
LanaWatkins, , Duke University
Additional Information:
Study ID Numbers: 919;
Study Start Date: June 1999
Record last reviewed: November 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00006311
Other Cardiovascular Diseases Studies:
1. Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients with Implantable Cardioverter Defibrillators
2. Beta-Blocker Heart Attack Trial (BHAT)
3. Evaluation of SC-V Versus Conventional CPR
4. Cardiac Arrhythmia Pilot Study (CAPS)
5. Technology Dependency and Health-Related Quality of Life
Related Studies:
Other Cardiovascular Diseases Clinical Trials
Other Clinical Trials
Other Clinical Trials
Anxiety and Vagal Control of the Heart in Coronary Disease
|
|
|
|
|
|
|
|
